The question of branded versus compounded GLP-1s comes up a lot, but the conversation often misses the most important distinction. 😂 Most of what patients receive are patient-specific prescriptions from a 503A pharmacy, not bulk batches from a 503B outsourcing facility. That’s a 503A question, not a 503B one, and the distinction actually matters here because the standards and oversight are different. When you get a branded pen like Ozempic or Mounjaro, you’re getting a product with a known, fixed quantity of active pharmaceutical ingredient (API), specific inactive ingredients (excipients), and a massive data package submitted to the FDA proving its sterility and stability up to